Clinical Trials Sponsored by Cantex Healthcare Centers, LLC

Total 1231 results

M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC

Terminated

Vorinostat Plus Radiation Therapy in Pancreatic Cancer

Pancreatic Cancer

United States
M.D. Anderson Cancer Center
Janssen Scientific Affairs, LLC

Not yet recruiting

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

Prostate Cancer | Prostatectomy | Androgen Axis Suppression

United States
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC

Recruiting

Spanish Decision Tool for Ovarian Cancer Maintenance Therapy

Ovarian Cancer

United States
National Cancer Center, Japan
Merck Sharp & Dohme LLC

Recruiting

First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis) (Artemis)

Untreated Advanced or Recurrent Thymic Carcinomas

Japan
Jonsson Comprehensive Cancer Center
Merck Sharp & Dohme LLC

Recruiting

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia

Cervical Intraepithelial Neoplasia | Cervical Squamous Cell Carcinoma In Situ | Cervical Squamous Intraepithelial Neoplasia 2

United States
Memorial Sloan Kettering Cancer Center
AstraZeneca; MedImmune LLC

Active, not recruiting

RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers

Thyroid Cancer

United States
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC

Completed

PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Fred Hutchinson Cancer Center
Merck Sharp & Dohme LLC

Completed

Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines

Tuberculosis

United States
Jonsson Comprehensive Cancer Center
Merck Sharp & Dohme LLC

Completed

Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate

Urothelial Carcinoma | Castration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Bladder Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage III Urethral Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Stage IV Urethral... and other conditions

United States
Fox Chase Cancer Center
Merck Sharp & Dohme LLC

Terminated

Study of MK-3475 Alone or in Combination With Copanlisib in Relapsed or Refractory NK and T-cell Non-Hodgkin Lymphoma

Lymphoma, T-Cell, Peripheral

United States
M.D. Anderson Cancer Center
Janssen Scientific Affairs, LLC

Completed

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Cancer | Pulmonary Embolism | Non-valvular Atrial Fibrillation | Deep-vein Thrombosis of the Lower and Upper Extremities

United States
Memorial Sloan Kettering Cancer Center
AstraZeneca; MedImmune LLC

Completed

Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer

Advanced Colorectal Cancer

United States
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC

Active, not recruiting

Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme | Anaplastic Glioma

United States
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC

Completed

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

Sarcoma | Chemotherapy-induced Nausea and Vomiting | Effects of Chemotherapy | Adverse Effects of Medical Drugs

United States
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC

Completed

SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma

Lymphoma

United States
National Cancer Center, Korea
Merck Sharp & Dohme LLC

Unknown

Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC)

Non-Small-Cell Lung Carcinoma

Korea, Republic of
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC

Terminated

Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma

Lymphoma

United States
The Dale & Frances Hughes Cancer Center
MedImmune LLC

Completed

Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities

Head and Neck Cancer | Lung Cancer

United States
Sarcoma Oncology Research Center, LLC

Recruiting

Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Leiomyosarcoma (TAGGED)

Leiomyosarcoma

United States
PhenoSolve, LLC
Jacobi Medical Center

Completed

Validating a New Non-invasive Approach to Testing Lidocaine Effectiveness

ADHD | Controls

United States
MetaProteomics LLC
Boston Medical Center

Terminated

Effects of a Novel Dietary Intervention on Body Composition After Laparoscopic Gastric Bypass Surgery

Obesity | Morbid Obesity

United States
Erasmus Medical Center
The Dutch Healthcare Authority

Recruiting

Innovation for Small-scale Experiments: ReceptIVFity Test (ReceptIVFity)

Pregnancy Related | Infertility, Female | Subfertility, Female

Netherlands
Rabin Medical Center
Fisher and Paykel Healthcare

Recruiting

Nasal High Flow Therapy in the Paediatric Home Setting (HFNC)

Lung Diseases | Respiratory Disease

Israel
Tufts Medical Center
Fisher and Paykel Healthcare

Completed

Pilot Study of High-flow Humidified Nasal Oxygen During Breaks From Noninvasive Ventilation (OPTINIV)

Acute Respiratory Failure | Treatment With Noninvasive Positive Pressure Ventilation

United States
Sheba Medical Center
Maccabi Healthcare Services, Israel

Recruiting

HAPPCAP-AD (Human-APPlication Combined Approach for Prevention of Alzheimer's Disease) (HAPPCAP-AD)

Alzheimer Disease

Israel
Erebouni Medical Center
Fisher and Paykel Healthcare

Recruiting

ROX Index and ROX Vector to Predict Nasal High Flow / Continuous Positive Airway Pressure Failure in Neonates

Predictive Value of Tests

Armenia
Tel-Aviv Sourasky Medical Center
Owlytics Healthcare

Recruiting

Modelling Missteps to Improve Fall Risk Assessment.

Fall Patients

Israel
Erebouni Medical Center
Fisher and Paykel Healthcare

Completed

Effect of Cannula Size on Oxygen Saturation During Nasal High Flow Therapy in Newborns

TTN | RDS - Infants

Armenia
Vanderbilt University Medical Center
Baxter Healthcare Corporation

Terminated

Peripheral Venous Analysis (PIVA) for Predicting Volume Responsiveness and Fluid Status (PIVA)

Systemic Inflammatory Response Syndrome | Atrial Fibrillation | Hypotension and Shock | Distributive Shock | Decompensated Congestive Heart Failure | High Risk Non-cardiac Surgery

United States
Sheba Medical Center
Maccabi Healthcare Services, Israel

Completed

CCT for Older Diabetic Adults

Diabetes | Older Diabetic Persons Without Dementia

Israel
Sheba Medical Center
Maccabi Healthcare Services, Israel

Terminated

Disease Management in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Patients (ACDM-Maccabi)

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

Israel
Sheba Medical Center
Maccabi Healthcare Services, Israel

Completed

Israeli Judicious Antibiotic Prescription Study (IJAP)

Antibiotic Use | Carriage of Antibiotic Resistant Pathogens
Samsung Medical Center
Fisher and Paykel Healthcare

Not yet recruiting

Asymmetric High-flow Nasal Cannula (HFNC) vs Standard HFNC for Post Extubation High-risk Group

Acute Respiratory Failure

Korea, Republic of
Assaf-Harofeh Medical Center
Gama Healthcare Ltd.

Completed

The Impact of Bedside Wipes in Multi-patient Rooms: a Prospective, Crossover Trial Evaluating Infections and Survival

Hospital Acquired Infection

Israel
Tufts Medical Center
Fisher and Paykel Healthcare

Completed

Pilot Study of Physiological Effect of High-Flow Nasal Cannula on Respiratory Pattern and Work of Breathing

COPD

United States
Vanderbilt University Medical Center
Baxter Healthcare Corporation

Completed

Testing Tissue Sodium Stores in CAPD Patients-Aims 1 & 2

End Stage Renal Disease

United States
Vanderbilt University Medical Center
Baxter Healthcare Corporation

Completed

Descriptive Study of Cardiac Output During Rehydration With Recombinant Human Hyaluronidase in Pediatrics (Hylenex)

Dehydration | Pediatrics | Cardiac Output

United States
Genuine Research Center, Egypt
Pharmed Healthcare, Egypt

Completed

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Healthy

Egypt
Danish Center for Healthcare Improvement
Institute for Quality and Accreditation in Healthcare

Unknown

Unannounced Periodic Surveys on Public Hospitals

Accreditation

Denmark
National Opinion Research Center
Centers for Disease Control and Prevention; Emory Healthcare

Completed

Evaluating the Cost Effectiveness of STEADI (STEADI)

Accidental Fall

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Pharmacyclics LLC.

Completed

A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer

Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC

Recruiting

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Glioma

United States
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC

Recruiting

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

Hodgkin Lymphoma | Relapsed or Refractory Hodgkin Lymphoma

United States
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC

Recruiting

Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]

Bladder Cancer

United States
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC; AstraZeneca

Active, not recruiting

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

Prostate Carcinoma | Prostate Cancer Aggressiveness

United States
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC; Celgene

Active, not recruiting

Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma

Metastatic Melanoma | Melanoma and Other Malignant Neoplasms of Skin

United States
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC

Active, not recruiting

Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma

Adrenocortical Carcinoma

United States
UNC Lineberger Comprehensive Cancer Center
Merck Sharp & Dohme LLC

Active, not recruiting

High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML

Acute Myeloid Leukemia, in Relapse

United States
Memorial Sloan Kettering Cancer Center
Janssen Scientific Affairs, LLC

Completed

Short Course Daratumumab in Patients With Multiple Myeloma

Multiple Myeloma

United States
Memorial Sloan Kettering Cancer Center
Janssen Scientific Affairs, LLC

Active, not recruiting

Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis

Multiple Myeloma | AL Amyloidosis

United States

Clinical Trials Sponsored by Cantex Healthcare Centers, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations